This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Trading Rebound to Support Raymond James' (RJF) Q2 Earnings
by Zacks Equity Research
Reversal in trading activities, stable underwriting fees and higher interest rates are expected to support Raymond James' (RJF) Q2 earnings.
Morgan Stanley (MS) Restates Q4 Earnings on U.S. Tax Reform
by Zacks Equity Research
Morgan Stanley (MS) revises its 2017 earnings per share by 2 cents.
Raymond James Financial (RJF) Down 6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Raymond James Financial (RJF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WisdomTree (WETF) Shares Fall on Q4 Earnings Miss, Costs Up
by Zacks Equity Research
WisdomTree Investments (WETF) Q4 results reflect higher expenses. Strong advisory fees and assets under management were some positives.
Investment Managers' Earnings on Jan 24: AMP, RJF, LM, SEIC
by Zacks Equity Research
Ameriprise (AMP), Raymond James (RJF), SEI Investments (SEIC) and Legg Mason's (LM) results might benefit from improved investment banking. Yet, fall in trading revenues might be a drag.
Can Underwriting Fees Aid Raymond James (RJF) Q1 Earnings?
by Zacks Equity Research
Driven by improvement in underwriting fees, Raymond James' (RJF) Q1 earnings will likely improve despite trading weakness and lower advisory fees.
Zacks.com highlights: Raymond James Financial, Cognizant Technology Solutions, Applied Materials, Church & Dwight and Total System Services
by Zacks Equity Research
Zacks.com highlights: Raymond James Financial, Cognizant Technology Solutions, Applied Materials, Church & Dwight and Total System Services
5 Best Stocks with Impressive Sales Growth Worth Buying
by Zacks Equity Research
Among several stock-picking strategies, we chose a rational, down-to-earth investment approach - one that focuses on sales growth of a company.
Zacks.com featured highlights include: AngioDynamics, Zumiez, GP Strategies, AngloGold and Raymond James
by Zacks Equity Research
Zacks.com featured highlights include: AngioDynamics, Zumiez, GP Strategies, AngloGold and Raymond James
Bet on These 5 PEG-Ratio Based GARP Picks
by Zacks Equity Research
A lower PEG ratio, preferably less than one, is always better for GARP investors.
GAIN Capital (GCAP) in Focus: Stock Moves 5.2% Higher
by Zacks Equity Research
GAIN Capital (GCAP) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
Time to Focus on Raymond James (RJF) for Strong Earnings Growth Potential
by Zacks Equity Research
Raymond James (RJF) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
The Zacks Analyst Blog Highlights: MGIC Investment, Moody's, American Express, E*TRADE Financial and Raymond James Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MGIC Investment, Moody's, American Express, E*TRADE Financial and Raymond James Financial
5 Large-Cap Financial Stocks That Crushed the Market in 2017
by Zacks Equity Research
These stocks should continue their stellar run in the New Year on improving industry backdrop and optimism over the movements of the Fed and Trump administration.
SEI Investments Ups Dividend: Is There More Upside Left?
by Zacks Equity Research
SEI Investments' (SEIC) 7% dividend hike reflects its strong balance sheet position. Also, the stock has significant upside potential driven by strong fundamentals.
Franklin (BEN) Announces 15% Dividend Hike: Time to Hold?
by Zacks Equity Research
Franklin announced 15% increase in the quarterly common stock dividend to 23 cents per share. The new dividend will be paid on Jan 10, 2018, to shareholders of record as of Dec 26, 2017.
Zacks.com featured highlights: CBRE, Raymond James Financial, Huntington Ingalls Industries, DTE Energy and AMETEK
by Zacks Equity Research
Zacks.com featured highlights: CBRE, Raymond James Financial, Huntington Ingalls Industries, DTE Energy and AMETEK
5 Best Stocks With Solid Sales Growth to Keep an Eye On
by Zacks Equity Research
Sales growth is an important indicator of a company's health and ability to sustain its business. It provides investors an insight into product demand and pricing power.
Can Raymond James (RJF) Stock Continue to Grow Earnings?
by Zacks Equity Research
Raymond James (RJF) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
Top Stock Reports for BP Plc, Mitsubishi UFJ & Netflix
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including BP Plc (BP), Mitsubishi UFJ (MTU) and Netflix (NFLX).
Will Underwriting Fees Aid Raymond James (RJF) Q4 Earnings?
by Zacks Equity Research
A marginal improvement in underwriting fees is expected to support Raymond James' (RJF) Q4 earnings while trading slowdown and mounting costs might hurt bottom line.
Schwab (SCHW) Beats on Q3 Earnings as Interest Income Rises
by Zacks Equity Research
Schwab's (SCHW) Q3 earnings improved on higher net interest income while lower trading income acted as a headwind.
Top Ranked Momentum Stocks to Buy for October 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 4th:
The Zacks Analyst Blog Highlights: Mastercard, Raymond James Financial, Constellation Brands, Amphenol and Royal Caribbean Cruises
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, Raymond James Financial, Constellation Brands, Amphenol and Royal Caribbean Cruises
5 Top Stocks for Marvelous Gains in October
by Tirthankar Chakraborty
October is not likely to put an end to the bull market, while equities have a reputation of maintaining gains as the fourth quarter is usually the strongest.